Sinopharm Group Co. Ltd.
1099
Classificação em ações
#2952
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of... Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Preço da ação
$2.00
Valor de mercado
$6.26B
Variação (1 dia)
1.95%
Variação (1 ano)
-16.78%
País
CN
Negociar Sinopharm Group Co. Ltd. (1099)
Categoria
Healthcare
Rácio P/E de Sinopharm Group Co. Ltd. (1099)
Rácio P/E em October 2026 TTM: 5.95
De acordo com os últimos relatórios financeiros e o preço das ações da Sinopharm Group Co. Ltd., o rácio P/E atual (TTM) é 5.95. No final de 2023, a empresa tinha um P/E de 6.31.
Histórico do rácio P/E da Sinopharm Group Co. Ltd. de 2006 a 2026
Rácio P/E no final de cada ano
| Ano | Índice P/E | Alterar |
|---|---|---|
| 2026 (TTM) | 5.95 | -32.88% |
| 2024 | 8.86 | 40.36% |
| 2023 | 6.31 | -1.62% |
| 2022 | 6.41 | 15.78% |
| 2021 | 5.54 | -19.36% |
| 2020 | 6.87 | -3.35% |
| 2019 | 7.11 | -22.00% |
| 2018 | 9.11 | -15.07% |
| 2017 | 10.73 | -36.83% |
| 2016 | 16.98 | -11.33% |
| 2015 | 19.15 | -3.06% |
| 2014 | 19.76 | 1.48% |
| 2013 | 19.47 | -17.93% |
| 2012 | 23.72 | 3.89% |
| 2011 | 22.83 | -46.94% |
| 2010 | 43.03 | -17.01% |
| 2009 | 51.85 | 59.01% |
| 2008 | 32.61 | -38.42% |
| 2007 | 52.95 | -68.18% |
| 2006 | 166.42 | 0.00% |
Rácio P/E para empresas semelhantes ou concorrentes
| Empresa | Rácio P/E | Diferença do rácio P/E | País |
|---|---|---|---|
| 26.02 | 337.53% |
US
|
|
| - | - |
US
|
|
| 34.08 | 472.99% |
US
|
|
| - | - |
US
|
|
| 45.62 | 667.03% |
AU
|
Como interpretar um P/E Ratio?
O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.
Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.
Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.